Target intelligence / Profile preview

Menin–MLL histone methyltransferase complex

Molecular classification
Other, Histone modification, Transcription factor
01

Overview

The term “Menin–MLL2 complex” refers to a **protein–protein interaction within the larger MLL1/MLL2 COMPASS-like histone methyltransferase complexes**, rather than a stand‑alone, uniquely defined receptor or enzyme. Menin is an ubiquitously expressed nuclear protein that binds the N‑termini of **MLL1 (KMT2A)** and **MLL2 (KMT2B)**, which are SET‑domain lysine methyltransferases that catalyze histone H3 lysine 4 (H3K4) methylation in large multi‑subunit complexes containing core WRAD subunits (WDR5, RbBP5, ASH2L, DPY30) and other cofactors[1][2]. Menin is a common, near‑stoichiometric component of wild‑type MLL1 and MLL2 complexes and is required for their transcriptional activity, facilitating recruitment to target genes and maintenance of H3K4me3 at promoters of bivalent developmental genes and HOX/MEIS1 loci[1][2][3]. The **menin–MLL interaction pocket** on menin recognizes short N‑terminal menin‑binding motifs (MBM1, MBM2) from MLL1/MLL2, and crystal structures show that small‑molecule inhibitors such as **MI‑2 and MI‑2‑2** bind in this pocket, closely mimicking key contacts of the MLL MBM1 peptide and thereby competitively inhibiting the menin–MLL interaction[2]. Disruption of this interaction preferentially impairs leukemogenic MLL fusion protein complexes (MLL‑FPs), which are highly dependent on menin to bridge binding to chromatin (via LEDGF and other partners), and thus the **menin–MLL complex is considered a validated therapeutic epigenetic target** in MLL‑rearranged leukemias[2][3].

Other names
Menin–KMT2A/MLL1 complexMenin–KMT2B/MLL2 complexMenin–MLL interactionMenin–MLL1/MLL2 complexMenin–Trithorax (Trx) complex
02

Mechanism of action

Small-molecule inhibitors bind to the central pocket of menin, competitively blocking the high‑affinity menin‑binding motif (MBM1) of MLL1/MLL2, thereby disrupting the menin–MLL protein–protein interaction, dislodging MLL complexes from target genes, and downregulating oncogenic transcription programs such as HOX/MEIS1 in MLL‑rearranged leukemias[2][3].

03

Biological functions

Epigenetic regulationGene transcriptional activationHistone H3 lysine 4 (H3K4) methylationRegulation of developmental and differentiation genesRegulation of HOX and MEIS1 gene expressionStem cell and germ cell differentiationMaintenance of open chromatin at target promoters
04

Disease associations

CancerOther
05

Safety considerations

Potential on‑target effects on normal MLL1/MLL2–menin function in hematopoiesis and development (given menin is an integral component of wild‑type MLL1/MLL2 complexes required for H3K4 methylation at target genes)possible broad epigenetic/transcriptional perturbation due to disruption of menin association with endogenous MLL1/MLL2 complexes[1][2][3]
06

Interacting drugs

MI-2

2 more in the full profile.

07

Biomarkers

MLL (KMT2A) rearrangements or fusionshigh HOXA9 and MEIS1 expressiondependency on menin–MLL interaction in leukemia cells[2][3]

Beyond the preview

Go deeper on Menin–MLL histone methyltransferase complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Menin–MLL histone methyltransferase complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call